Patricof & Co. Ventures

IMG Academy is 'a feel-good deal where we knew that we were investing in a company where we would generate a nice private equity return but also investing in the future of ultimately thousands of kids.'

Over 50 of P/Co’s athlete clients took part in this investment, including Dak Prescott, Michelle Wie West, Jason Kelce, CC Sabathia, Justin Jefferson and Steve Kerr.

Asset managers’ partnerships with prominent sports figures are moving beyond a purely branding exercise.

Berwyn, Pennsylvania-based Complexa Inc, a biopharmaceutical company, has named Francisco D. Salva as CEO and president. His appointment is effective immediately. Previously, Salva was founder and vice president of operations for Acerta Pharma B.V. Complexa's backers include Andera Partners, HBM Healthcare Investments, JAFCO, New Enterprise Associates and Pfizer Venture Investments.

Seattle-based venture firm Alpine BioVentures has appointed Dr. Jay Venkatesan as a managing partner. Venkatesan is the former executive vice president and general manager of Oncothyreon Inc, which he joined after it was acquired by Alpine Biosciences. Also, he was a founder, portfolio manager and managing director of Ayer Capital Management.

Keek Inc (TSX-V: KEK), a mobile video social network, has appointed David Birnbaum to its board of directors. Birnbaum is the president of Broadway Video Ventures, the corporate strategy, venture capital investment and acquisition arm of U.S.-based Broadway Video Entertainment Inc. He is also a former investment professional at British private equity firm Apax Partners. Update: Based in Toronto, Keek has been backed by a number of private equity and venture capital firms since 2011.

Toronto-based Keek, a free social video platform provider, has appointed David Birnbaum to its board of directors. Birnbaum is the president of Broadway Video Ventures, the corporate strategy, investment and acquisition arm of Broadway Video Entertainment. He is also a former investment professional at Apax Partners.

Genesis Biopharma said Tuesday that it has named Sanford J. Hillsberg and Dr. Jay Venkatesan to its board of directors, effective in two weeks. Also, Paul Kessler and David Voyticky have resigned as directors, also effective in two weeks. Previously, Hillsberg was the chairman of the executive committee of Medco Research. Dr. Venkatesan is the founder, portfolio manager and managing director of Ayer Capital Management, a global healthcare equity fund. Based in Los Angeles, Genesis Biopharma is a company focused on developing treatments for cancer.

The US arm of Apax Partners, the global private equity firm, and US middle-market veteran Saunders, Karp & Megrue will combine operations with John Megrue and Allan Karp at the helm.

Greycroft Partners will likely raise a second fund in 2009, having already backed 24 startups with its first